AVON, Conn.--(BUSINESS WIRE)--Magellan Pharmacy Solutions, a division of Magellan Health Services (NASDAQ: MGLN), will host its 10th annual Oncology Summit – What You Don’t Know Can Hurt You – on September 18 and 19 in Baltimore, Maryland. In addition to highlighting the emerging medical pharmacy trends in the rapidly changing specialty market, the summit will also feature a discussion about the impact of healthcare reform on the oncology field, led by Harlan Levine, M.D., Chief Executive at City of Hope Medical Foundation.
“It’s critical that we have a better understanding of how healthcare reform has already and will continue to impact the field of oncology”
Dr. Levine will discuss, in part, how the Affordable Care Act has prompted oncology practices to reorganize to deliver and demonstrate greater value, and why early adopters will be positioned well to succeed.
The two-day summit will bring together the leading authorities on oncology care, benefits management, pharmaceuticals, and research to discuss the latest developments and strategies for managing oncology, as well as specialty healthcare. In addition to the impact of healthcare reform, topics this year include:
- Key Industry Medical Pharmacy Management Updates
- Novel Chemotherapies
- Disease Management in Specialty Pharmacy
- Case Studies in Multiple Sclerosis and Rheumatoid Arthritis Management
- Oncology Site of Service Challenges
- End of Life Medical Management
“It’s critical that we have a better understanding of how healthcare reform has already and will continue to impact the field of oncology,” said Michael Waterbury, president of ICORE, a division of Magellan Pharmacy Solutions. “For the past decade, this summit has focused on emerging trends, best practices and other experiences in the rapidly changing field of oncology and specialty pharmacy as a whole to help providers, payers, pharmaceutical companies and our colleagues best understand how to help our patients and the members we serve.”
The summit is open to representatives from health plans, oncology practices, specialty pharmacies, pharmaceutical manufacturers, employers and consultants. Those interested in attending can find registration information at www.ICOREHealthcare.com/Summit.aspx.
Magellan Pharmacy Solutions offers a suite of options to help manage total drug spend, including the categories of oral, injectable and infusible drugs, to improve engagement and quality and safety of care, while lowering costs for consumers, health plans, states and employers. Magellan’s medical pharmacy program covers approximately nine million medical lives. Earlier this year, Magellan Pharmacy Solutions released its third annual Medical Pharmacy & Oncology Trend Report, the only benchmark of its kind to analyze medical injectable data and explaining the trends surrounding specialty medications such as those used to treat complex chronic conditions like cancer, rheumatoid arthritis and multiple sclerosis.
Media inquiries should be directed to Colleen Flanagan Johnson at CEFJohnson@MagellanHealth.com.
About Magellan Health Services: Headquartered in Avon, Conn., Magellan Health Services Inc. is a leading specialty health care management organization with expertise in managing behavioral health, radiology, and pharmacy benefits programs, as well as integrated health care programs for special populations. Magellan delivers innovative solutions to improve quality outcomes and optimize the cost of care for those we serve. As of June 30, 2013, Magellan's customers include health plans, employers and government agencies, serving approximately 34.0 million members in our behavioral health business, 17.4 million members in our radiology benefits management segment, and approximately 9 million members in our medical pharmacy management product. In addition, the pharmacy solutions segment served 40 health plans and employers, 25 states and the District of Columbia, and several pharmaceutical manufacturers. For more information, visit www.MagellanHealth.com.